Save the New Tetracycline Omadacycline (Nuzyra) as a Last Resort
You'll see a new, once-daily, IV and PO tetracycline antibiotic, omadacycline (Nuzyra, noo-ZYE-rah).
It's approved for community-acquired pneumonia (CAP)...or skin infections, including methicillin-resistant Staph aureus (MRSA).
Evidence suggests omadacycline is non-inferior to moxifloxacin for CAP or linezolid for skin infections. And omadacycline costs about $350/IV dose or $400/oral dose.
Get unlimited access through an Enterprise license
Hospital Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 300+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Not sold to individuals